Literature DB >> 2457568

On the alcianophilia of the drug suramin used as a tool for inducing experimental mucopolysaccharidosis.

B Christensen1, R Lüllmann-Rauch.   

Abstract

The trypanocidal drug suramin was previously reported to induce mucopolysaccharidosis in rats; apart from the biochemical demonstration of increased tissue concentrations of sulfated glycosaminoglycans (GAGs), a strongly positive staining reaction with the cationic dye Alcian Blue was taken as indicating GAG-storage (Constantopoulos et al. 1983). The purpose of the present report is to point out a methodical pitfall. In model experiments it was found that suramin itself, being a polysulfated compound, gives a strongly positive reaction with Alcian Blue at pH 1. It is known that suramin is accumulated in the lysosomes and that high drug concentrations are retained in the tissues for weeks. Therefore a positive staining reaction with Alcian Blue observed in a given cell cannot be conclusively attributed to the storage of sulfated GAGs as has been done in the past. The present report may be a warning that, in the case of the suramin-induced animal model of mucopolysaccharidosis, the usual histochemical strategy, i.e. staining with cationic dyes, is not suitable for analysing the cellular distribution pattern of GAG-storage, since the inducing drug by itself reacts with the indicator dye.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457568     DOI: 10.1007/bf00500638

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  19 in total

1.  SPECIFIC STAINING OF SULPHATE GROUPS WITH ALCIAN BLUE AT LOW PH.

Authors:  R LEV; S S SPICER
Journal:  J Histochem Cytochem       Date:  1964-04       Impact factor: 2.479

2.  [Cellular partition and storage mechanism of Bayer 205 (Germanin) in the tissues].

Authors:  N JANCSO; A JANCSO-GABOR
Journal:  Acta Physiol Acad Sci Hung       Date:  1952

3.  Studies on Bayer 205 (Germanin) and Antrypol: The retention of the drug in the animal body.

Authors:  J C Boursnell; A Wormall
Journal:  Biochem J       Date:  1939-08       Impact factor: 3.857

4.  Spectroscopic studies on the complex formation of suramin with bovine and human serum albumin.

Authors:  W E Müller; U Wollert
Journal:  Biochim Biophys Acta       Date:  1976-04-14

Review 5.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

Review 6.  The genetic mucopolysaccharidoses (GMS).

Authors:  M D Haust
Journal:  Int Rev Exp Pathol       Date:  1973

7.  Suramin (Bayer 205) in animal tissues; demonstration of Bayer 205 (suramin) in tissues and its cellular distribution.

Authors:  N JANCSO; A JANCSO-GABOR
Journal:  Nature       Date:  1952-10-04       Impact factor: 49.962

8.  Organomegaly and histopathology in an animal model of mucopolysaccharidosis induced by suramin.

Authors:  S Rees; G Constantopoulos; J A Barranger; R O Brady
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

9.  The suramin-treated rat as a model of mucopolysaccharidosis: reversibility of biochemical and morphological changes in the liver.

Authors:  S Rees; G Constantopoulos; R Brady
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

10.  Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

Authors:  G Constantopoulos; S Rees; B G Cragg; J A Barranger; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  2 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Suramin-induced mucopolysaccharidosis in rat incisor.

Authors:  A Gritli; D Septier; M Goldberg
Journal:  Cell Tissue Res       Date:  1993-07       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.